Neuromark System
Payments companies reported to CMS as associated with Neuromark System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuromark System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuromark System
These are the largest totals companies reported as associated with Neuromark System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ronald Kuppersmith | College Station, TX | Otolaryngology | $90,805.83 |
| Marc Dubin | Baltimore, MD | Otolaryngology | $74,180.43 |
| Richard Manes | New Haven, CT | Otolaryngology | $50,242.81 |
| Greg Davis | Puyallup, WA | Otolaryngology | $27,451.21 |
| Kibwei Mckinney | Oklahoma City, OK | Otolaryngology | $16,096.38 |
| Anthony Delsignore | New York, NY | Otolaryngology | $15,516.90 |
| Eugene Brown | Charleston, SC | Otolaryngology | $13,559.90 |
| Michael Kaplan | Houston, TX | Otolaryngology | $12,498.27 |
| Ryan Vaughn | Schaumburg, IL | Otolaryngology/Facial Plastic Surgery | $8,638.78 |
| Michael Sillers | Birmingham, AL | Otolaryngology | $7,367.54 |
Prescribed Neuromark System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.